Overview
Hitomi Mori practices practicing medicine in Fukuoka, Japan.
Ms. Mori is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Triple-Negative Breast Cancer, and Agranulocytosis.
She is actively involved in clinical research, co-authoring 15 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hitomi Mori
Is Hitomi Mori a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Hitomi Mori is classified as an Advanced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hitomi Mori participate in research or clinical trials?
Yes. Hitomi Mori has published 15 articles and abstracts on conditions like Breast Cancer. You can view a list of Hitomi Mori's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerMs. Mori isAdvanced. Learn about Breast Cancer.
- Experienced
- AgranulocytosisMs. Mori isExperienced. Learn about Agranulocytosis.
- Lung MetastasesMs. Mori isExperienced. Learn about Lung Metastases.
- PIK3CA-Related Overgrowth SpectrumMs. Mori isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Triple-Negative Breast CancerMs. Mori isExperienced. Learn about Triple-Negative Breast Cancer.